WAYNE, Pa. (AP) — WAYNE, Pa. (AP) — Aclaris Therapeutics Inc. (ACRS) on Thursday reported a loss of $96.6 million in its fourth quarter.
The Wayne, Pennsylvania-based company said it had a loss of $1.01 per share. Losses, adjusted for non-recurring costs, came to 10 cents per share.
The results surpassed Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for a loss of 32 cents per share.
The specialty pharmaceutical company posted revenue of $9.2 million in the period, also beating Street forecasts. Five analysts surveyed by Zacks expected $2.2 million.
For the year, the company reported that its loss widened to $132.1 million, or $1.71 per share. Revenue was reported as $18.7 million.
The company’s shares closed at $2.10. A year ago, they were trading at $1.21.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ACRS at https://www.zacks.com/ap/ACRS
Copyright © 2025 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.
